Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

Gelijkaardige items

• The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial
  door: Oscier, David, et al.
  Gepubliceerd in: (2016)
• ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
  door: Rose-Zerilli, Matthew J.J., et al.
  Gepubliceerd in: (2014)
• Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial
  door: Larrayoz, M, et al.
  Gepubliceerd in: (2017)
• The long‐term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years
  door: Else, Monica, et al.
  Gepubliceerd in: (2015)
• The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial
  door: Else, Monica, et al.
  Gepubliceerd in: (2021)